Mettler-Toledo International, Inc. MTD

1,511.64 (7.51) (0.49%) as of 25 Sep
Market cap
$30.4B
P/E
33.9×
Indexes indicate stock being part of an index

Mettler-Toledo International, Inc. (MTD) Gross margin

Mettler-Toledo International, Inc.'s gross margin over the twelve months to 30 June 2026 was 60.3%, up 0.9 percentage points from fiscal 2025 (59.4%). Over the past ten years it has ranged from 56.4% (fiscal 2015) to 60.1% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of 50.9% and above the Healthcare sector median of 53.7%.

Gross margin, annual

Annual

Period Gross margin Change (points)
FY2025 59.4% (0.69)
FY2024 60.1% 0.90
FY2023 59.2% 0.28
FY2022 58.9% 0.47
FY2021 58.4% 0.03
FY2020 58.4% 0.51
FY2019 57.9% 0.49
FY2018 57.4% (0.44)
FY2017 57.8% 0.50
FY2016 57.3% 0.88

Quarterly

Period Gross margin Change (points)
Jun 2026 63.3% 4.61
Mar 2026 58.7% (1.11)
Dec 2025 59.8% 0.60
Sep 2025 59.2% 0.21
42 more quarters

Against its own ten years

Low 56.4% High 60.1%
Ten-year median 58.4%
Current reading's percentile 91

Gross margin against peers

Company Gross margin
ILMN Illumina, Inc. compare 66.4%
GH Guardant Health, Inc. compare 65.0%
IDXX IDEXX Laboratories, Inc. compare 62.5%
MTD Mettler-Toledo International, Inc. 60.3%
A Agilent Technologies, Inc. compare 53.8%
WAT Waters Corporation compare 50.9%
DGX Quest Diagnostics Incorporated compare 33.1%
IQV IQVIA Holdings Inc. compare 33.0%
LH Labcorp Holdings Inc. compare 28.9%
Diagnostics & Research industry median 50.9%
Healthcare sector median 53.7%
Market median 46.3%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on MTD